|
 |
| |
Jiangxi Yuehua Pharmaceutical Co.,Ltd. ,established in 1968 is a subsidiary of Jingdezhen Black Cat Group (a National Top 500 manufacturer with annual output of ¥18.5 billion). Located in the world-renowned "Porcelain Capital" of Jingdezhen, the company is adjacent to National Highway 206, Hangzhou-Ruili Expressway, and Jiguang Expressway, enjoying convenient transportation, superior geographical location, and a pleasant environment. |
| |
Since relocating to Jingdezhen National High-Tech Industrial Park in 2018, Yuehua has developed into a comprehensive pharmaceutical fine chemical enterprise integrating the production of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, organic solvents, and new materials.Focusing on its core API business, Yuehua has built competitive advantages in specialized segments and has earned numerous accolades, including:CEP, etc.
Based on the integrated development strategy of the "API + Preparation" industrial chain, its main product piracetam (Naofukang) API ranks second globally in production and sales. Its New material adhesives are applied in the latest superconducting materials in domestic and foreign optoelectronic new energy fields.. Cyclopropyl pharmaceutical intermediates fill the gap in raw materials for the production of domestic anti-cancer new drugs. The successful commissioning of the penicillamine API project will effectively alleviate the current shortage of domestic medications.Furthermore, its fosfomycin series API project will become a model of the most advanced antibiotic production processes at home and abroad. |
|
|
|
|
